Longitudinal Cohort of Thrombosis and Hemostasis Diseases

ConditionsImmune Thrombocytopenia Thrombotic Thrombocytopenic Purpura Hemophilia A, Acquired Disseminated Intravascular Coagulation Thrombophilia Deep Vein Thrombosis Pulmonary Embolism Thrombotic Microangiopathies Coagulation Factor Deficiency Hemophilia A Hemophilia B Hemophilia B, Acquired Platelet Dysfunction Arterial Thromboembolism Bleeding Disorder Thrombosis

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorPeking University People's Hospital

About this trial

This is a multicenter, prospective, longitudinal, observational cohort study to investigate thrombosis and hemostasis diseases in Chinese patients. This study will collect basic information, diagnostic and treatment information, as well as medical expense information of patients from medical records.The incidence and risk factors of thrombosis and hemostasis diseases, the treatment methods, prognosis and medical expenses of these patients in China will be analyzed. The study will use questionnaire to measure the exposure of patients, and prospectively follow-up to collect the prognosis information.

Eligibility criteria

Qualifiers

Patients who were diagnosed as thrombosis and hemostasis diseases.

Disqualifiers

Long-term follow-up information for patients is not available for any reason, such as not being available or having a serious concomitant disease.

Patients with alcohol and drug addictions or mental illness affect their ability to comply with study requirements.

According to the investigator, there are conditions that may endanger the patient's safety or affect his/her compliance.

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Peking University People's Hospital

Lead sponsor

Source ClinicalTrials.gov